Soluble urokinase plasminogen activator receptor predicts cardiovascular events, mortality and kidney function decline in patients with type 1 diabetes

被引：0
|
作者：
Curovic, V. Rotbain [1 ]
Theilade, S. [1 ]
Winther, S. A. [1 ]
Tofte, N. [1 ]
Eugen-Olsen, J. [2 ]
Persson, F. [1 ]
Hansen, T. W. [1 ]
Jeppesen, J. [3 ,4 ]
Rossing, P. [1 ,4 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[2] Hvidovre Univ Hosp, Clin Res Ctr, Hvidovre, Denmark
[3] Amager Hvidovre Hosp, Dept Med, Glostrup, Denmark
[4] Univ Copenhagen, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1183
引用
收藏
页码：S577 / S578
页数：2
相关论文
共 50 条
  • [1] Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes
    Curovic, Viktor Rotbain
    Theilade, Simone
    Winther, Signe A.
    Tofte, Nete
    Eugen-Olsen, Jesper
    Persson, Frederik
    Hansen, Tine W.
    Jeppesen, Jorgen
    Rossing, Peter
    DIABETES CARE, 2019, 42 (06) : 1112 - 1119
  • [2] Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease
    Iversen, Esben
    Kallemose, Thomas
    Hornum, Mads
    Bengaard, Anne Kathrine
    Nehlin, Jan Olof
    Rasmussen, Line Jee Hartmann
    Sandholdt, Haakon
    Tavenier, Juliette
    Feldt-Rasmussen, Bo
    Andersen, Ove
    Eugen-Olsen, Jesper
    Houlind, Morten Baltzer
    CLINICAL KIDNEY JOURNAL, 2022, 15 (08) : 1534 - 1541
  • [3] Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
    Eugen-Olsen, J.
    Andersen, O.
    Linneberg, A.
    Ladelund, S.
    Hansen, T. W.
    Langkilde, A.
    Petersen, J.
    Pielak, T.
    Moller, L. N.
    Jeppesen, J.
    Lyngbaek, S.
    Fenger, M.
    Olsen, M. H.
    Hildebrandt, P. R.
    Borch-Johnsen, K.
    Jorgensen, T.
    Haugaard, S. B.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (03) : 296 - 308
  • [4] Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
    Godtfredsen, Nina S.
    Jorgensen, Ditte, V
    Marsaa, Kristoffer
    Ulrik, Charlotte S.
    Andersen, Ove
    Eugen-Olsen, Jesper
    Rasmussen, Line J. H.
    RESPIRATORY RESEARCH, 2018, 19
  • [5] Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
    Nina S. Godtfredsen
    Ditte V. Jørgensen
    Kristoffer Marsaa
    Charlotte S. Ulrik
    Ove Andersen
    Jesper Eugen-Olsen
    Line J. H. Rasmussen
    Respiratory Research, 19
  • [6] Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease
    Hayek, Salim S.
    Landsittel, Douglas P.
    Wei, Changli
    Zeier, Martin
    Yu, Alan S. L.
    Torres, Vicente E.
    Roth, Sharin
    Pao, Christina S.
    Reiser, Jochen
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (07): : 1305 - 1313
  • [7] Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness
    Chew-Harris, J. S.
    Appleby, S.
    Richards, A. M.
    Troughton, R. W.
    Pemberton, C. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1573 - 1573
  • [8] Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD
    Jorgensen, Ditte Vendelbo
    Godtfredsen, Nina Skalvan
    Marsaa, Kristoffer
    Ulrik, Charlotte Suppli
    Andersen, Ove
    Eugen-Olsen, Jesper
    Rasmussen, Line Jee Hartmann
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [9] Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome
    Raggam, R. B.
    Wagner, J.
    Prueller, F.
    Grisold, A.
    Leitner, E.
    Zollner-Schwetz, I.
    Valentin, T.
    Krause, R.
    Hoenigl, M.
    JOURNAL OF INTERNAL MEDICINE, 2014, 276 (06) : 651 - 658
  • [10] Soluble urokinase plasminogen activator receptor is elevated in diabetes and associated with diabetic complications in patients with type 1 diabetes
    Theilade, S.
    Lyngbaek, S.
    Hansen, T. W.
    Eugen-Olsen, J.
    Fenger, M.
    Rossing, P.
    Jeppesen, J.
    DIABETOLOGIA, 2014, 57 : S508 - S508
12345